Case Study

Pioneering Adoptive Cell Therapy: TFS Delivers Successful Study Start-up Amidst the COVID-19 Pandemic

June 10, 2024November 18th, 2024
Pioneering Adoptive Cell Therapy

Pioneering Adoptive Cell Therapy: TFS Delivers Successful Study Start-up Amidst the COVID-19 Pandemic

Discover how TFS successfully supported a European biotech company in launching a groundbreaking adoptive cell therapy study amidst the global disruptions caused by the COVID-19 pandemic. This case study provides an in-depth look at TFS’s strategic approach and solutions that led to a successful study start-up.

What You’ll Learn:

  • How TFS overcame regulatory and logistical challenges
  • Key strategies for managing ATMP studies during a crisis
  • The critical role of communication and project management in clinical trials

Download the complete case study to explore the innovative strategies and expert insights that drove this remarkable achievement.

Learn more about our related services and resources:

TFS Oncology & Hematology

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Oncology & Hematology Expertise

ASCO Oncology
10 oncology trial readouts to watch for at ASCO 2026Article

10 oncology trial readouts to watch for at ASCO 2026

Biomarker-defined populations. Rare cancers. Multi-country designs. As ASCO 2026 approaches, TFS HealthScience outlines the ten oncology trials that matter most and what they mean for sponsors planning their next programme.
The Value of Cross-Functional Expertise in Complex Oncology Clinical TrialsArticle

The Value of Cross-Functional Expertise in Complex Oncology Clinical Trials

Experienced Oncology CROs with cross-functional expertise strengthen complex oncology clinical trials and accelerates clinical development.
Customisation, partnerships and AI the keys to the future of clinical trials
From Strategy to Patients: Adaptability and Innovation in Trial DesignArticle

From Strategy to Patients: Adaptability and Innovation in Trial Design

Explore how adaptability, innovation, and patient focus can help sponsors rethink trial execution, from smarter sourcing models to the role of AI in oncology.